C4X Discovery Holdings plc (C4XD) — Delisted · Historical data & RNS archive | Ticker
Going concern No material uncertainty
Principal risks 3 23 Apr 2026 Annual Report and Accounts (to 2025-12-31) 29 Jan 2024 Annual Report and Accounts (to 2023-07-31) 27 Jan 2023 Annual Report and Accounts (to 2022-07-31)
EA
Eva-Lotta Allan Chairman
– CD
Clive Dix Executive Chairman
– David Lawrence Non-Executive Chairman
1 yrs 11 mos RJ
Richard Jones Non-Executive Director
– DM
Dr Mario Polywka Non-Executive Director
– C4X Discovery is a company that uses advanced Drug Discovery technologies and scientific knowledge to create innovative medicines. These medicines are developed in collaboration with partners to improve the health of patients.
Industry Health Care
Sector Health Care
LEI 213800UHNL82E323O870
Region Europe
Admission date 23 Oct 2014
Going concern No material uncertainty
Principal risks 3 23 Apr 2026 Annual Report and Accounts (to 2025-12-31) 29 Jan 2024 Annual Report and Accounts (to 2023-07-31) 27 Jan 2023 Annual Report and Accounts (to 2022-07-31)
EA
Eva-Lotta Allan Chairman
– CD
Clive Dix Executive Chairman
– David Lawrence Non-Executive Chairman
1 yrs 11 mos RJ
Richard Jones Non-Executive Director
– DM
Dr Mario Polywka Non-Executive Director
– C4X Discovery is a company that uses advanced Drug Discovery technologies and scientific knowledge to create innovative medicines. These medicines are developed in collaboration with partners to improve the health of patients.
Industry Health Care
Sector Health Care
LEI 213800UHNL82E323O870
Region Europe
Admission date 23 Oct 2014
Shares in issueas at 31 Jul 2020
119,200,000
Total Voting Rights 9,266,058
Average employeesFY Jul 2020 46
Latest year FY25
Dividend No dividend declared
ISIN GB00BQQ2RV18
Exchange —
Market Aim
Shares in issueas at 31 Jul 2020
119,200,000
Total Voting Rights 9,266,058
Average employeesFY Jul 2020 46
Latest year FY25
Dividend No dividend declared
ISIN GB00BQQ2RV18
Exchange —
Market Aim